Broker Recommendations

Barclays downgrades Haleon to 'equalweight', says question marks over US persist

By Michele Maatouk

Date: Tuesday 16 Sep 2025

(Sharecast News) - Barclays downgraded GSK's consumer health spinoff Haleon on Tuesday to 'equalweight' from 'overweight' as it said questions marks persist over the US and there are "a few new clouds on the horizon".
The bank noted that the US accounts for 34% of sales and said it is seeing...

Sign up for free or to read the full story

Email this article to a friend

or share it with one of these popular networks:


Article Archive

Top of Page